FINDELL CAPITAL MANAGEMENT LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$347.8B
Holdings
15
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 4,207,449 | $145.1B | 41.73% | Put |
| 2 | ESTAESTABLISHMENT LABS HLDGS INC | 1,130,460 | $82.4B | 23.69% | |
| 3 | ROOTROOT INC | 235,000 | $17.0B | 4.88% | |
| 4 | DAVEDAVE INC | 70,000 | $15.5B | 4.46% | |
| 5 | TPBTURNING PT BRANDS INC | 127,000 | $13.8B | 3.96% | |
| 6 | OPRTOPORTUN FINL CORP | 2,568,300 | $13.6B | 3.91% | |
| 7 | SGHCSUPER GROUP SGHC LIMITED | 940,000 | $11.2B | 3.23% | |
| 8 | GEGGEO GROUP INC NEW | 650,000 | $10.5B | 3.01% | |
| 9 | CELHCELSIUS HLDGS INC | 210,000 | $9.6B | 2.76% | |
| 10 | EHTHEHEALTH INC | 1,408,975 | $6.5B | 1.86% | |
| 11 | ABVXABIVAX SA | 48,000 | $6.5B | 1.86% | |
| 12 | LRNSTRIDE INC | 90,000 | $5.8B | 1.68% | |
| 13 | ADMAADMA BIOLOGICS INC | 300,000 | $5.5B | 1.57% | |
| 14 | VORVOR BIOPHARMA INC | 231,000 | $3.0B | 0.87% | |
| 15 | MLYSMINERALYS THERAPEUTICS INC | 50,000 | $1.8B | 0.52% |